Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II (Q28592264)

From Wikidata

Jump to navigation Jump to search

scientific journal article

Language	Label	Description	Also known as
English	Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II	scientific journal article

Statements

scholarly article

1 reference

31 January 2017

Targeted disruption of the acid alpha-glucosidase gene in mice causes an illness with critical features of both infantile and adult human glycogen storage disease type II (English)

1 reference

31 January 2017

Glucosidase, alpha, acid

1 reference

GOA release 2020-03-11

glycogen storage disease

1 reference

based on heuristic

inferred from title

author name string

N. Raben

1

1 reference

31 January 2017

K. Nagaraju

2

1 reference

31 January 2017

E. Lee

3

1 reference

31 January 2017

P. Kessler

4

1 reference

31 January 2017

B. Byrne

5

1 reference

31 January 2017

L. Lee

6

1 reference

31 January 2017

M. LaMarca

7

1 reference

31 January 2017

C. King

8

1 reference

31 January 2017

J. Ward

9

1 reference

31 January 2017

B. Sauer

10

1 reference

31 January 2017

P. Plotz

11

1 reference

31 January 2017

language of work or name

0 references

publication date

24 July 1998

1 reference

31 January 2017

Journal of Biological Chemistry

1 reference

31 January 2017

273

1 reference

31 January 2017

19086–19092

1 reference

31 January 2017

30

1 reference

31 January 2017

Generalized glycogen storage and cardiomegaly in a knockout mouse model of Pompe disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Intravenous administration of phosphorylated acid alpha-glucosidase leads to uptake of enzyme in heart and skeletal muscle of mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Lysosomal storage diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Prospect for enzyme therapy in glycogenosis II variants: a study on cultured muscle cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

High-level production of recombinant human lysosomal acid alpha-glucosidase in Chinese hamster ovary cells which targets to heart muscle and corrects glycogen accumulation in fibroblasts from patients with Pompe disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Complete correction of acid alpha-glucosidase deficiency in Pompe disease fibroblasts in vitro, and lysosomally targeted expression in neonatal rat cardiac and skeletal muscle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Clinical and metabolic correction of pompe disease by enzyme therapy in acid maltase-deficient quail

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Glycogenosis type II: a juvenile-specific mutation with an unusual splicing pattern and a shared mutation in African Americans

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Isolation of a cDNA for human acid alpha-glucosidase and detection of genetic heterogeneity for mRNA in three alpha-glucosidase-deficient patients

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Efficient in vivo manipulation of mouse genomic sequences at the zygote stage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Glycogenosis type II (acid maltase deficiency)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Glycogen storage disease type II: frequency of three common mutant alleles and their associated clinical phenotypes studied in 121 patients

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Mouse models of human genetic disease: which mouse is more like a man?

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Animal models of human disease for gene therapy

1 reference

https://api.crossref.org/works/10.1074%2FJBC.273.30.19086

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28592264&oldid=1532153046"